-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Hematologic Toxicity of Checkpoint Inhibitors

Program: Education Program
Session: Hematologic Toxicity of Immunotherapies
Saturday, December 9, 2023, 4:00 PM-5:15 PM

Michael Kroll, MD

MD Anderson Cancer Ctr., Houston, TX

Disclosures: No relevant conflicts of interest to declare.